Zachary B. Fleming - Jul 5, 2022 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)

Role
Chief Executive Officer
Signature
/s/ Zachary B. Fleming
Stock symbol
SMTI
Transactions as of
Jul 5, 2022
Transactions value $
-$37,564
Form type
4
Date filed
7/7/2022, 05:18 PM
Previous filing
Jun 30, 2022
Next filing
Nov 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMTI Common Stock Sale -$5.68K -265 -0.68% $21.45 38.7K Jul 5, 2022 Direct F1, F2
transaction SMTI Common Stock Sale -$14.6K -665 -1.72% $22.00 38K Jul 6, 2022 Direct F1
transaction SMTI Common Stock Sale -$17.3K -750 -1.97% $23.00 37.3K Jul 6, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $22.00, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.